Charles Schwab Investment Management Inc Spero Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 28,565 shares of SPRO stock, worth $68,841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,565
Previous 28,565
-0.0%
Holding current value
$68,841
Previous $82,000
35.37%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SPRO
# of Institutions
51Shares Held
10.6MCall Options Held
0Put Options Held
65.7K-
Vanguard Group Inc Valley Forge, PA1.99MShares$4.8 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.6MShares$3.86 Million0.5% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.45MShares$3.5 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.26 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.14 Million0.1% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $84.5M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...